Science News

Scientists Shed New Light on Gender Differences in Alzheimer’s

Women have a 1 in 6 chance and men have a 1 in 11 change of developing Alzheimer's during the remainder of their lives at age 65
Sabine Katharina Mosch, University of Luxembourg
New research is shedding light on what drives the vast gender disparity in Alzheimer’s – men have a 1 in 11 chance of developing the disease, but yet for women the odds are 1 in 6 even when accounting for their longer life span.

Supported by a grant from BrightFocus Foundation’s Alzheimer’s Disease Research program, a team of scientists at the University of Luxembourg has discovered that a particular gene could be an important clue to dramatic gender differences in the rate and expression of Alzheimer’s disease.  According to lead scientist Dr. Enrico Glaab, the gene may help identify targets for anti-Alzheimer treatments in the future.

The researchers report that a gene, ubiquitin-specific peptidase 9 (USP9), appears to provide some protection against the disease in men through its interaction with another gene that helps regulate tau proteins. Tau, like amyloid-beta (Aβ), is a protein that is present in the normal-functioning brain, but found in higher levels in the Alzheimer’s brain.

The team found that blocking the USP9 gene significantly reduced the activity of the tau gene. From this evidence comes the hope that USP9 could be an effective target for future therapies.  While encouraging, more research is needed before it will be possible to develop anti-Alzheimer’s drugs based on this principle.

Dr. Glaab and his lab pursued this research after winning the 2013 Global NeuroDiscovery Challenge, supported by the Geoffrey Beene Alzheimer’s Initiative, 21st Century Brain Trust, WomenAgainst Alzheimer’s Network, and BrightFocus Foundation (grant no. C2014002). The research is also sponsored by the Luxembourg Fondation Wivine.

This content was first posted on: January 11, 2017

The information provided in this section is a public service of BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.

Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Keep me informed about: *
Please select at least one.
You must select at least one disease category.
Please enter your first name.
Please enter your last name.